The mission of the UF Health Cancer Center Clinical Research Office, or CRO, is to help deliver new and promising cancer treatments that improve the lives of our patients at the UF Health Cancer Center. The CRO provides support to our clinical investigators for the development and implementation of cancer clinical trials — facilitating the conduct of high-quality clinical research while adhering to the highest ethical standards and maintaining compliance with all governing bodies.
The Clinical Research Office is committed to supporting clinical research addressing the complex needs of the catchment area and the patients we serve, with an emphasis on providing access to novel cancer treatments. The office provides comprehensive resources to investigators for the efficient conduct of cancer clinical research with representative inclusion of minorities, women, and individuals across the lifespan.
Currently, the clinical research program consists of the CRO and 11 disease-specific working groups (e.g., thoracic, GI, GU, neuro-oncology, hematologic malignancies). It also supports an experimental therapeutics group for early phase clinical trials as well as a Cancer Control and Population Sciences group. These two groups support trials that may be relevant to patients across several different cancer types.
Thomas J. George, M.D., FACP
Medical Director, Clinical Research Office
Associate Director of Clinical Research
UF Health Cancer Center
The Clinical Research Office provides the following services to the clinical investigators of the UF Health Cancer Center
View open clinical trials.
The UF Health Cancer Center IIT Think Tank (I2T3) is a dedicated monthly forum for investigators to refine, discuss, collaborate, and collect feedback on new investigator-initiated concepts.
Each group is charged with developing and maintaining a portfolio of trials that brings forward scientific hypotheses developed in the Research Programs and is relevant to our catchment area.
The SRMC provides the critical review of scientific merit, methodology and validity of statistical analyses of cancer-relevant studies prior to activation.
The DISC is a multidisciplinary committee comprised of UFHCC investigators and staff.
The Clinical Trials Auditing Team provides ongoing auditing for complex through low risk clinical trials.